Search

Author/Creator Havard, Diane

1. Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053). Issue 2 (February 2019)

Authors:
Appleton, Jason P; Scutt, Polly; Dixon, Mark; Howard, Harriet; Haywood, Lee; Havard, Diane; Hepburn, Trish; England, Tim; Sprigg, Nikola; Woodhouse, Lisa J; Wardlaw, Joanna M; Montgomery, Alan A; Pocock, Stuart; Bath, Philip M
Journal:
International journal of stroke
Issue:
Volume 14:Issue 2(2019)
Page Start:
191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Issue 10123 (3rd March 2018)

Authors:
Bath, Philip M; Woodhouse, Lisa J; Appleton, Jason P; Beridze, Maia; Christensen, Hanne; Dineen, Robert A; Duley, Lelia; England, Timothy J; Flaherty, Katie; Havard, Diane; Heptinstall, Stan; James, Marilyn; Krishnan, Kailash; Markus, Hugh S; Montgomery, Alan A; Pocock, Stuart J; Randall, Marc; R...
Journal:
Lancet
Issue:
Volume 391:Issue 10123(2018)
Page Start:
850
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage (DASH): protocol for a phase II double-blind randomised controlled feasibility trial. Issue 11 (10th November 2020)

Authors:
Desborough, Michael J R; Al-Shahi Salman, Rustam; Stanworth, Simon J; Havard, Diane; Brennan, Paul M; Dineen, Robert A; Coats, Timothy J; Hepburn, Trish; Bath, Philip M; Sprigg, Nikola
Journal:
BMJ open
Issue:
Volume 10:Issue 11(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗